183 related articles for article (PubMed ID: 763270)
1. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump.
Tamborlane WV; Sherwin RS; Genel M; Felig P
N Engl J Med; 1979 Mar; 300(11):573-8. PubMed ID: 763270
[TBL] [Abstract][Full Text] [Related]
2. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
[TBL] [Abstract][Full Text] [Related]
3. [Improvement in the treatment of diabetes by means of a portable insulin-infusion apparatus. Preliminary results in 4 unstable juvenile diabetics].
Porr O; Morell B; Walter H; Sturzenegger J; Froesch ER
Schweiz Med Wochenschr; 1980 Nov; 110(47):1761-3. PubMed ID: 7006076
[TBL] [Abstract][Full Text] [Related]
4. Insulin-infusion-pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels.
Tamborlane WV; Hintz RL; Bergman M; Genel M; Felig P; Sherwin RS
N Engl J Med; 1981 Aug; 305(6):303-7. PubMed ID: 7017416
[TBL] [Abstract][Full Text] [Related]
5. Continuous intravenous insulin therapy with a miniaturized open-loop system.
Renner R; Hepp KD; Mehnert H; Franetzki M
Horm Metab Res Suppl; 1979; (8):186-90. PubMed ID: 395077
[TBL] [Abstract][Full Text] [Related]
6. Outpatient treatment of juvenile-onset diabetes with a preprogrammed portable subcutaneous insulin infusion system.
Tamborlane WV; Sherwin RS; Genel M; Felig P
Am J Med; 1980 Feb; 68(2):190-6. PubMed ID: 6986766
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of unstable diabetes with a portable insulin-infusion pump (author's transl)].
Talaulicar M; Willms B
Dtsch Med Wochenschr; 1982 Mar; 107(11):419-23. PubMed ID: 7037348
[TBL] [Abstract][Full Text] [Related]
8. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
9. The effect of asymptomatic nocturnal hypoglycemia on glycemic control in diabetes mellitus.
Perriello G; De Feo P; Torlone E; Calcinaro F; Ventura MM; Basta G; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
N Engl J Med; 1988 Nov; 319(19):1233-9. PubMed ID: 3054544
[TBL] [Abstract][Full Text] [Related]
10. Failure of nocturnal hypoglycemia to cause fasting hyperglycemia in patients with insulin-dependent diabetes mellitus.
Tordjman KM; Havlin CE; Levandoski LA; White NH; Santiago JV; Cryer PE
N Engl J Med; 1987 Dec; 317(25):1552-9. PubMed ID: 3317053
[TBL] [Abstract][Full Text] [Related]
11. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
Saccà L; Sherwin R; Hendler R; Felig P
J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
[TBL] [Abstract][Full Text] [Related]
12. A portable, pre-programmable insulin infusion system in diabetes mellitus.
Kølendorf K; Bojsen J
Horm Metab Res Suppl; 1979; (8):191-3. PubMed ID: 395078
[TBL] [Abstract][Full Text] [Related]
13. [Ambulatory treatment of diabetes in children by continuous subcutaneous infusion of insulin using a portable pump].
Bougnères PF; Landier F; Lemmel C; Golse B; Chaussain JL
Arch Fr Pediatr; 1984 Jan; 41(1):27-33. PubMed ID: 6721650
[TBL] [Abstract][Full Text] [Related]
14. Diabetes responsive to intravenous but not subcutaneous insulin: effectiveness of aprotinin.
Freidenberg GR; White N; Cataland S; O'Dorisio TM; Sotos JF; Santiago JV
N Engl J Med; 1981 Aug; 305(7):363-8. PubMed ID: 7019707
[TBL] [Abstract][Full Text] [Related]
15. [Continuous subcutaneous insulin infusion brings about normal blood sugar in type I diabetes mellitus despite relaxing of diet instructions].
Sonnenberg GE; Chantelau E; Altenähr H; Berger M; Berchtold P
Schweiz Med Wochenschr; 1982 Jan; 112(3):83-5. PubMed ID: 7036337
[TBL] [Abstract][Full Text] [Related]
16. Preprogrammed insulin infusion with a portable pump system.
Irsigler K; Kritz H; Kaspar L; Brändle J; Koller W; Franetzki M
Horm Metab Res Suppl; 1979; (8):193-7. PubMed ID: 119699
[TBL] [Abstract][Full Text] [Related]
17. Continuous subcutaneous insulin infusion fails to correct impaired basal glucose metabolism and impaired insulin sensitivity of adipocytes from patients with type 1 (insulin-dependent) diabetes.
Pedersen O; Hjøllund E; Beck-Nielsen H; Richelsen B; Sørensen NS
Diabetes Res; 1986 Jan; 3(1):17-23. PubMed ID: 3514067
[TBL] [Abstract][Full Text] [Related]
18. Insulin-mediated glucose disposal in type 1 (insulin-dependent) diabetic subjects treated by continuous subcutaneous or intraperitoneal insulin fusion.
Beylot M; Khalfallah Y; Laville M; Sautot G; Dechaud H; Serusclat P; Berthezene F; Riou JP; Mornex R
Diabete Metab; 1987; 13(4):450-6. PubMed ID: 3315766
[TBL] [Abstract][Full Text] [Related]
19. Substitution of basal delivery of insulin by proinsulin in type I diabetic patients under CSII.
Kerner W; Wallmüller G; Beischer W; Pfeiffer EF
Horm Metab Res Suppl; 1988; 18():74-7. PubMed ID: 3056816
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of automating insulin delivery for the treatment of type 1 diabetes.
Steil GM; Rebrin K; Darwin C; Hariri F; Saad MF
Diabetes; 2006 Dec; 55(12):3344-50. PubMed ID: 17130478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
